Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

Jeffrey Wong, MD, discusses the unmet needs in prostate cancer treatment, especially in regard to radiopharmaceuticals.

Screening for the condition is not currently recommended because using the current test - which looks for levels of prostate specific antigen (PSA) in the blood - can falsely find men who do not ...

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

There is a general consensus among clinicians that a serum prostate-specific antigen ... within a prespecified range. Prostate cancer is surprisingly prevalent in men with serum PSA levels ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

He added: “Every week someone is writing to me to say hearing my story made them get a PSA (prostate-specific antigens ... We had the primary cancers for men and women at the same time.

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment for metastatic prostate cancer. In March, the hospital began administering ...